Therefore, based on our case and the previous cases reported, it is recommended that patients with MS on interferon beta be regularly monitored for any sign of abnormal platelet counts, elevated liver enzymes, and abnormal RBCs in blood smear tests for any sign of the "triad" which could indicate TTP-HUS development. The gene discussed is IFNB1; the disease is hemolytic-uremic syndrome.